191 related articles for article (PubMed ID: 20882620)
1. Characterization of cirrhotic nodules with gadoxetic acid-enhanced magnetic resonance imaging: the efficacy of hepatocyte-phase imaging.
Chou CT; Chen YL; Su WW; Wu HK; Chen RC
J Magn Reson Imaging; 2010 Oct; 32(4):895-902. PubMed ID: 20882620
[TBL] [Abstract][Full Text] [Related]
2. Characterization of hyperintense nodules on precontrast T1-weighted MRI: utility of gadoxetic acid-enhanced hepatocyte-phase imaging.
Chou CT; Chen YL; Wu HK; Chen RC
J Magn Reson Imaging; 2011 Mar; 33(3):625-32. PubMed ID: 21563246
[TBL] [Abstract][Full Text] [Related]
3. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI
Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
[TBL] [Abstract][Full Text] [Related]
4. Optimal scanning protocol of arterial dominant phase for hypervascular hepatocellular carcinoma with gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced MR.
Kagawa Y; Okada M; Kumano S; Katsube T; Imaoka I; Tanigawa N; Ishii K; Kudo M; Murakami T
J Magn Reson Imaging; 2011 Apr; 33(4):864-72. PubMed ID: 21448951
[TBL] [Abstract][Full Text] [Related]
5. Gadoxetic acid disodium-enhanced hepatocyte phase MRI: can increasing the flip angle improve focal liver lesion detection?
Haradome H; Grazioli L; Al manea K; Tsunoo M; Motosugi U; Kwee TC; Takaraha T
J Magn Reson Imaging; 2012 Jan; 35(1):132-9. PubMed ID: 21960465
[TBL] [Abstract][Full Text] [Related]
6. Using Gd-EOB-DTPA-enhanced 3-T MRI for the differentiation of infiltrative hepatocellular carcinoma and focal confluent fibrosis in liver cirrhosis.
Park YS; Lee CH; Kim BH; Lee J; Choi JW; Kim KA; Ahn JH; Park CM
Magn Reson Imaging; 2013 Sep; 31(7):1137-42. PubMed ID: 23688409
[TBL] [Abstract][Full Text] [Related]
7. Early hepatocellular carcinomas showing isointensity or hyperintensity in gadoxetic acid-enhanced, hepatocyte-phase magnetic resonance images.
Chen N; Motosugi U; Sano K; Ichikawa T; Nakano M; Morisaka H; Ichikawa S; Matsuda M; Fujii H; Enomoto N; Araki T
J Comput Assist Tomogr; 2013; 37(3):466-9. PubMed ID: 23674023
[TBL] [Abstract][Full Text] [Related]
8. Double-dose gadoxetic Acid-enhanced magnetic resonance imaging in patients with chronic liver disease.
Motosugi U; Ichikawa T; Sano K; Sou H; Onohara K; Muhi A; Kitamura T; Amemiya F; Enomoto N; Matsuda M; Asakawa M; Fujii H; Araki T
Invest Radiol; 2011 Feb; 46(2):141-5. PubMed ID: 21139506
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte-specific magnetic resonance imaging contrast agents.
Fidler J; Hough D
Hepatology; 2011 Feb; 53(2):678-82. PubMed ID: 21274888
[No Abstract] [Full Text] [Related]
10. Is gadoxetic acid-enhanced MRI limited in tumor characterization for patients with chronic liver disease?
Kwon S; Kim YK; Park HJ; Jeong WK; Lee WJ; Choi D
Magn Reson Imaging; 2014 Dec; 32(10):1214-22. PubMed ID: 25192607
[TBL] [Abstract][Full Text] [Related]
11. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of liver parenchyma after injection of hepatocyte-specific MRI contrast media: a comparison of gadoxetic acid and gadobenate dimeglumine.
Filippone A; Blakeborough A; Breuer J; Grazioli L; Gschwend S; Hammerstingl R; Heinz-Peer G; Kittner T; Laghi A; Leen E; Lencioni R; Lucidarme O; Remplik P; Robinson PJ; Ruehm SG; Schaefer F; Stoupis C; Tombach B; Valette PJ; Zech CJ; Huppertz A
J Magn Reson Imaging; 2010 Feb; 31(2):356-64. PubMed ID: 20099349
[TBL] [Abstract][Full Text] [Related]
13. Value of delayed hypointensity and delayed enhancing rim in magnetic resonance imaging diagnosis of small hepatocellular carcinoma in the cirrhotic liver.
Khan AS; Hussain HK; Johnson TD; Weadock WJ; Pelletier SJ; Marrero JA
J Magn Reson Imaging; 2010 Aug; 32(2):360-6. PubMed ID: 20677263
[TBL] [Abstract][Full Text] [Related]
14. Focal liver lesion detection and characterization with GD-EOB-DTPA.
Purysko AS; Remer EM; Veniero JC
Clin Radiol; 2011 Jul; 66(7):673-84. PubMed ID: 21524416
[TBL] [Abstract][Full Text] [Related]
15. Staging liver fibrosis by using liver-enhancement ratio of gadoxetic acid-enhanced MR imaging: comparison with aspartate aminotransferase-to-platelet ratio index.
Motosugi U; Ichikawa T; Oguri M; Sano K; Sou H; Muhi A; Matsuda M; Fujii H; Enomoto N; Araki T
Magn Reson Imaging; 2011 Oct; 29(8):1047-52. PubMed ID: 21775085
[TBL] [Abstract][Full Text] [Related]
16. Comparison of gadoxetic acid-enhanced MR imaging versus four-phase multi-detector row computed tomography in assessing tumor regression after radiofrequency ablation in subjects with hepatocellular carcinomas.
Yoon JH; Lee EJ; Cha SS; Han SS; Choi SJ; Juhn JR; Kim MH; Lee YJ; Park SJ
J Vasc Interv Radiol; 2010 Mar; 21(3):348-56. PubMed ID: 20116285
[TBL] [Abstract][Full Text] [Related]
17. Distinguishing hepatic metastasis from hemangioma using gadoxetic acid-enhanced magnetic resonance imaging.
Motosugi U; Ichikawa T; Onohara K; Sou H; Sano K; Muhi A; Araki T
Invest Radiol; 2011 Jun; 46(6):359-65. PubMed ID: 21427594
[TBL] [Abstract][Full Text] [Related]
18. Liver parenchymal enhancement of hepatocyte-phase images in Gd-EOB-DTPA-enhanced MR imaging: which biological markers of the liver function affect the enhancement?
Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Kitamura T; Araki T
J Magn Reson Imaging; 2009 Nov; 30(5):1042-6. PubMed ID: 19856436
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of Gd-BOPTA and Gd-DTPA in contrast-enhanced MR imaging of the liver].
Zhang HM; Ouyang H; Zhou CW
Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):111-5. PubMed ID: 16750014
[TBL] [Abstract][Full Text] [Related]
20. Paradoxical high signal intensity of hepatocellular carcinoma in the hepatobiliary phase of Gd-EOB-DTPA enhanced MRI: initial experience.
Lee SA; Lee CH; Jung WY; Lee J; Choi JW; Kim KA; Park CM
Magn Reson Imaging; 2011 Jan; 29(1):83-90. PubMed ID: 20832227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]